BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

533 related articles for article (PubMed ID: 31137841)

  • 21. Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche.
    Lock FE; McDonald PC; Lou Y; Serrano I; Chafe SC; Ostlund C; Aparicio S; Winum JY; Supuran CT; Dedhar S
    Oncogene; 2013 Oct; 32(44):5210-9. PubMed ID: 23208505
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nanomedicine strategies for sustained, controlled, and targeted treatment of cancer stem cells of the digestive system.
    Xie FY; Xu WH; Yin C; Zhang GQ; Zhong YQ; Gao J
    World J Gastrointest Oncol; 2016 Oct; 8(10):735-744. PubMed ID: 27795813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer Stem Cell for Tumor Therapy.
    Huang B; Yan X; Li Y
    Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer Stem Cell Metabolism and Potential Therapeutic Targets.
    Snyder V; Reed-Newman TC; Arnold L; Thomas SM; Anant S
    Front Oncol; 2018; 8():203. PubMed ID: 29922594
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Linking Tumor Microenvironment to Plasticity of Cancer Stem Cells: Mechanisms and Application in Cancer Therapy.
    Zheng X; Yu C; Xu M
    Front Oncol; 2021; 11():678333. PubMed ID: 34262865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PGE
    Lin MC; Chen SY; He PL; Herschman H; Li HJ
    Int J Cancer; 2018 Sep; 143(6):1440-1455. PubMed ID: 29658109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cancer stem cells in small cell lung cancer.
    Codony-Servat J; Verlicchi A; Rosell R
    Transl Lung Cancer Res; 2016 Feb; 5(1):16-25. PubMed ID: 26958490
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Can lung cancer stem cells be targeted for therapies?
    Wu X; Chen H; Wang X
    Cancer Treat Rev; 2012 Oct; 38(6):580-8. PubMed ID: 22436486
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting Cancer Stem Cells: Promises and Challenges.
    Kuhlmann JD; Hein L; Kurth I; Wimberger P; Dubrovska A
    Anticancer Agents Med Chem; 2016; 16(1):38-58. PubMed ID: 26179271
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting cancer stem cells in drug discovery: Current state and future perspectives.
    Du FY; Zhou QF; Sun WJ; Chen GL
    World J Stem Cells; 2019 Jul; 11(7):398-420. PubMed ID: 31396368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Implications and Future Perspectives of Nanomedicine for Cancer Stem Cell Targeted Therapies.
    Singh VK; Saini A; Chandra R
    Front Mol Biosci; 2017; 4():52. PubMed ID: 28785557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer Stem Cell and Gastrointestinal Cancer: Current Status, Targeted Therapy and Future Implications.
    Ahmad R; Dhawan P; Singh AB
    Biochem Pharmacol (Los Angel); 2016; 5(2):. PubMed ID: 31656694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Cancer Stem Cell in Hepatocellular Carcinoma.
    Schulte LA; López-Gil JC; Sainz B; Hermann PC
    Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32183251
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cancer Stem Cell-Based Models of Colorectal Cancer Reveal Molecular Determinants of Therapy Resistance.
    De Angelis ML; Zeuner A; Policicchio E; Russo G; Bruselles A; Signore M; Vitale S; De Luca G; Pilozzi E; Boe A; Stassi G; Ricci-Vitiani L; Amoreo CA; Pagliuca A; Francescangeli F; Tartaglia M; De Maria R; Baiocchi M
    Stem Cells Transl Med; 2016 Apr; 5(4):511-23. PubMed ID: 26956206
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Clinical Impact of Cancer Stem Cells.
    Lathia J; Liu H; Matei D
    Oncologist; 2020 Feb; 25(2):123-131. PubMed ID: 32043793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cancer stem cells (CSCs) in cancer progression and therapy.
    Najafi M; Farhood B; Mortezaee K
    J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cancer stem cells in hepatocellular carcinoma: an overview and promising therapeutic strategies.
    Wang N; Wang S; Li MY; Hu BG; Liu LP; Yang SL; Yang S; Gong Z; Lai PBS; Chen GG
    Ther Adv Med Oncol; 2018; 10():1758835918816287. PubMed ID: 30622654
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting tissue factor as a novel therapeutic oncotarget for eradication of cancer stem cells isolated from tumor cell lines, tumor xenografts and patients of breast, lung and ovarian cancer.
    Hu Z; Xu J; Cheng J; McMichael E; Yu L; Carson WE
    Oncotarget; 2017 Jan; 8(1):1481-1494. PubMed ID: 27903969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapies targeting cancer stem cells: Current trends and future challenges.
    Dragu DL; Necula LG; Bleotu C; Diaconu CC; Chivu-Economescu M
    World J Stem Cells; 2015 Oct; 7(9):1185-201. PubMed ID: 26516409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bmi-1: A master regulator of head and neck cancer stemness.
    Herzog AE; Somayaji R; Nör JE
    Front Oral Health; 2023; 4():1080255. PubMed ID: 36726797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.